Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 81

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 81
---
 Amendment, and we may continue to grant equity‑based awards under the Plan pursuant to its existing terms subject to shares remaining available for grant under the Plan.

Other than as set forth in the table below, neither our Board nor the Compensation Committee has made any determination to make future grants to any persons under the Amended Plan as of the date of this Proxy Statement. Therefore, it is not possible to determine the future benefits that will be received by these participants under the Amended Plan, or the benefits that would have been received by such participants if the Amended Plan had been in effect in the year ended December 31, 2024.

<div align='center'>54</div>

| Name and Position                                                                        |     | Dollar Value ($) |           |     | Number of Shares/Units (#) |    |
| Named Executive Officers:                                                                |     |                  |           |     |                            |    |
| Vivek Jain, Chief Executive Officer and Chairman of the Board                            |     |                  |         — |     |                            |  — |
| Brian Bonnell, Chief Financial Officer and Treasurer                                     |     |                  |         — |     |                            |  — |
| Christian B. Voigtlander, Chief Operating Officer                                        |     |                  |         — |     |                            |  — |
| Daniel Woolson, President                                                                |     |                  |         — |     |                            |  — |
| Virginia Sanzone, Corporate Vice President, General Counsel                              |     |                  |         — |     |                            |  — |
| All Current Executive Officers as a Group                                                |     |                  |         — |     |                            |  — |
| All Current Non-Executive Directors as a Group                                           |     |                  | 1,080,000 |     |                            | -1 |
| All Employees, Including all Current Officers who are not Executive Officers, as a Group |     |                  |         — |     |                            |  — |

________________________________

(1) The number of shares/units to be granted to non‑employee directors is not included in the table above as their equity award will depend on the value of our common stock on the grant date.

#### Plan Benefits
The table below sets forth summary information concerning the number of shares of our common stock subject to equity awards granted to certain persons under the Amended Plan as of March 8, 2025. The closing price of our stock on that date was $141.97.

Certain awards set forth in this table for the named